Stereotactic Body Radiation and Stereotactic Ablative Radiotherapy Therapy for Cancers 2nd edition
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 844
Special Issue Editors
Interests: SBRT/SABR; motion mitigation; 3D scintillation dosimetry and in vivo dosimetry; proton radiography and CT; FLASH RT
Special Issues, Collections and Topics in MDPI journals
Interests: radiation oncology; radiotherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Within the last decade, the radiation oncology community has witnessed increased adoption of hypofractionated, high-precision radiation therapy using stereotactic body radiation therapy (SBRT) or stereotactic ablative radiotherapy (SABR) across many disease sites such as Liver, Pancreas, Lung, and Prostate on the basis of clinical evidence demonstrating both efficacy and safety. The indication of SBRT/SABR is poised to greatly expand in the coming years for the management of oligometastatic disease. Technological advancements in precision patient alignment, in-room imaging, tumor motion management, and treatment machine deliveries have also emerged and followed suit.
Therefore, this Special Issue will include articles on all types of stereotactic modalities and treatments (SBRT, SABR, and others) using ultra-hypofractionated and hypofractionated high-dose-per-fraction regimens, including original research describing clinical outcomes and novel treatment planning and delivery approaches.
Submissions on the potential and use of AI and machine learning for SBRT/SABR treatment planning, tracking and alignment, and delivery are also welcome.
Prof. Dr. Sam Beddar
Dr. Michael D. Chuong
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiation therapy (oncology)
- stereotactic body radiation therapy (SBRT) and stereotactic ablative radiotherapy (SABR)
- ultra-hypofractionated and hypofractionated studies
- ablative/dose-escalated studies
- SBRT, SABR, and cyberknife technology
- MRI guidance
- tumor motion techniques and management
- frame and frameless immobilization devices
- SBRT/SABR dose constraints and toxicities
- artificial intelligence/machine learning
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
